De Novo device
Prolong
Ergon Medical , Ltd. · Vibrator For Climax Control Of Premature Ejaculation (PIA, Class II) · First FDA decision Mar 20, 2015, newest Mar 20, 2015Erectile dysfunction
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
35
Naming "Prolong"
MAUDE reports
427
Brand "Prolong", since 2015
PubMed studies
38,648
Mentioning "Prolong"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prolong
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PROLONGNew device typeDe Novo
DEN130047 · Decided Mar 20, 2015 · 487 days after receipt
Device type: Vibrator For Climax Control Of Premature Ejaculation (PIA) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prolong", any status and sponsor, newest update first.
- Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With ASDPivotal-lookingRecruiting
The Hong Kong Polytechnic UniversityAcademic, hospital or other
NCT05492032 · 150 participants (planned) · Start Jun 2, 2022 · Primary completion Sep 30, 2027
Device: Active-tDCS; Sham-tDCS · For: Transcranial Direct Current Stimulation; Autistic Spectrum Disorder; Electroencephalography and 1 more
Sites: Hung Hom, Hong Kong
Abbott Diabetes CarePublic (ABT)
NCT06668935 · 800 participants (planned) · Start Oct 24, 2024 · Primary completion Dec 2027
Device: To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists · For: Diabetes Mellitus
Sites: Paradise Valley, Arizona; Jacksonville, Florida; Miami Gardens, Florida · 8 sites in all
University of NebraskaAcademic, hospital or other
NCT06524856 · 20 participants (planned) · Start Oct 1, 2024 · Primary completion Mar 1, 2027
Device: Lung Master (Pulmonary Exerciser) · For: Dyspnea; Chronic Obstructive Pulmonary Disease; Asthma
Sites: Omaha, Nebraska
32 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prolong", and for the whole product code for context.
This brand
427 reports: 103 malfunction, 324 injury, 0 death
Whole product code PIA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- CR PROLONG 40MM BRNG STDInjury
0001822565-2026-03438 · Received Oct 15, 2026 · Event dated Jul 31, 2025
Device type: Shoulder Prosthesis, Reverse Configuration (PHX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pain; Joint Laxity
0001822565-2026-03105 · Received Sep 14, 2026
Device type: Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer (HSN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
0001822565-2026-02899 · Received Aug 19, 2026
Device type: Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer (HSN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Extraskeletal ossification; Pain; Loss of Range of Motion; Swelling/ Edema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Prolong"[tiab]. The summary above synthesizes these.
- Poor oral health may prolong COVID-19 illness.
Gupta S, Sorsa T, Brandt E, et al. · J Transl Med · 2022Letter, Research Support, Non-U.S. Gov't
- Power to prolong independence and healthy ageing in older adults.
Izquierdo M, Cadore EL · Br J Sports Med · 2024Editorial
- Prolong antiplatelet therapy. Where we stand?
Tousoulis D · Hellenic J Cardiol · 2019Editorial
- [Palliative medicine from deontology].
Bátiz Cantera J · Cuad Bioet · 2022English Abstract
- Commentary: Protect, prevent, prolongߪ.
Shahinian JH, Ruel M · J Thorac Cardiovasc Surg · 2022Editorial, Comment
- Therapeutic strategies to prolong gestation in preterm preeclampsia.
Provinciatto H, Araujo Júnior E, Granese R · J Obstet Gynaecol · 2025Editorial
- Measures to prolong duration of sensory block after regional anaesthesia.
Schubert AK, Wiesmann T, Dinges HC · Curr Opin Anaesthesiol · 2023Review
- [Prolong life...].
Kornacewicz-Jach Z · Kardiol Pol · 2011Comment
- Can We Safely Prolong QT in Long QT Syndrome Patients?
Napolitano C · JACC Clin Electrophysiol · 2025Editorial
- Acidosis can temporarily and markedly prolong APTT.
Sermon-Cadd AM, Beckett LJ, Kitchen S · Int J Lab Hematol · 2024Letter
- Aggressive local treatments may prolong survival but do not have curative intent.
Sugarbaker PH, Van der Speeten K · J Gastrointest Oncol · 2021Editorial, Comment
- How persister bacteria evade antibiotics, prolong infections.
Madhusoodanan J · Proc Natl Acad Sci U S A · 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.